Showing results (3031-3040 of 3,717) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|January 1, 1996
Active vs. passive resistance, dose-response relationships, high dose chemotherapy, and resistance modulation: a hypothesisD J Stewart, G P Raaphorst, J Yau, et al.Investigational New Drugs|January 1, 1996
Morpholinylanthracyclines: cytotoxicity and antitumor activity of differently modified derivativesM Ripamonti, L Capolongo, G Melegaro, et al.Investigational New Drugs|January 1, 1996
Phase I trial of a novel matrix metalloproteinase inhibitor batimastat (BB-94) in patients with advanced cancerS Wojtowicz-Praga, J Low, J Marshall, et al.Investigational New Drugs|January 1, 1996
A phase II trial of ilmofosine in non-small cell bronchogenic carcinomaP V Woolley, C J Schultz, G I Rodriguez, et al.Investigational New Drugs|January 1, 1996
Exploitation of folate and antifolate polyglutamylation to achieve selective anticancer chemotherapyJ J McGuire, T Tsukamoto, B P Hart, et al.Investigational New Drugs|January 1, 1996
A phase I clinical study of the antipurine antifolate lometrexol (DDATHF) given with oral folic acidS Laohavinij, S R Wedge, M J Lind, et al.Investigational New Drugs|January 1, 1996
Phase I trial of Adozelesin using the treatment schedule of daily x5 every 3 weeksB J Foster, P M LoRusso, E Poplin, et al.Investigational New Drugs|January 1, 1996
Phase I trial of intravenous carboplatin added to oral etoposide and oral cyclophosphamide for stage IV non-small cell lung cancerS M Grunberg, J Valentine, I Zackon, et al.Investigational New Drugs|January 1, 1996
Phase II trial of ZD1694 (Tomudex) in patients with advanced pancreatic cancerR Pazdur, N J Meropol, E S Casper, et al.Investigational New Drugs|January 1, 1995
Mitomycin C and menadione for the treatment of lung cancer: a phase II trialM Tetef, K Margolin, C Ahn, et al.Pageof 372